Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Investment firms purchase over 70,000 Pfizer shares, valued at $2.2M, as the company beats EPS estimates.
Investment firms have been buying Pfizer Inc. stock, with recent purchases totaling over 70,000 shares valued at about $2.2 million.
Pfizer reported EPS of $0.92, beating estimates by $0.25, though revenue was down 7.8% year-over-year.
The company offers medicines and vaccines and recently introduced COVID-19 products.
Pfizer has a market cap of $134.23 billion and a consensus target price of $29.17.
12 Articles
Las firmas de inversión compran más de 70,000 acciones de Pfizer, valoradas en $2.2M, ya que la compañía supera las estimaciones de EPS.